Optic Nerve Diffusion Measurement from Diffusion-Weighted Imaging in Optic Neuritis
Simon J. Hickmana,b,
Claudia A. M. Wheeler-Kingshotta,
Stephen J. Jonesc,
Katherine A. Miszkield,
Gareth J. Barkera,e,
Gordon T. Plantb and
David H. Millera
a NMR Research Unit, Department of Neuroinflammation, Institute of Neurology, University College London, London, United Kingdom
b Department of Neuro-Ophthalmology, Moorfields Eye Hospital, London, United Kingdom
c Department of Clinical Neurophysiology, National Hospital for Neurology and Neurosurgery, London, United Kingdom
d Department of Neuroradiology, National Hospital for Neurology and Neurosurgery, London, United Kingdom
e Institute of Psychiatry, Kings College London, London, United Kingdom

View larger version (64K):
[in a new window]
|
FIG 1. Orbital images from a 36-year-old woman 1 year after right-sided optic neuritis. Diseased optic nerve indicated by arrowhead, and contralateral healthy optic nerve indicated by arrow.
A, Nondiffusion weighted (b = 0) image.
B, ADC map.
C, FSE image demonstrating high signal intensity lesion in the right optic nerve.
D, sTE fFLAIR image demonstrating right optic nerve atrophy.
| |

View larger version (23K):
[in a new window]
|
FIG 2. Scatter graph showing ADCs for diseased optic nerves 1 year after acute optic neuritis, healthy contralateral optic nerves, and control optic nerves.
| |

View larger version (16K):
[in a new window]
|
FIG 3. Association between logMAR visual acuity and diseased optic nerve ADC (rS = 0.73; P = .001).
| |

View larger version (16K):
[in a new window]
|
FIG 4. Association between 1-year VEP central field amplitude and diseased optic nerve ADC (rS = 0.57, P = .021).
| |